The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The thresholds for statistical and clinical significance – a five-step procedure for evaluation of intervention effects in randomised clinical trials
Open accessAbstract
BACKGROUND: Thresholds for statistical significance are insufficiently demonstrated by 95% confidence intervals or P-values when assessing results from randomised clinical trials. First, a P-value only shows the probability of getting a result assuming that the null hypothesis is true and does not reflect the probability of getting a result assuming an alternative hypothesis to the null hypothesis is true. Second, a confidence interval or a P-value showing significance may be caused by multiplicity. Third, statistical significance does not necessarily result in clinical significance. Therefore, assessment of intervention effects in randomised clinical trials deserves more rigour in order to become more valid. METHODS: Several methodologies for assessing the statistical and clinical significance of intervention effects in randomised clinical trials were considered. Balancing simplicity and comprehensiveness, a simple five-step procedure was developed. RESULTS: For a more valid assessment of results from a randomised clinical trial we propose the following five-steps: (1) report the confidence intervals and the exact P-values; (2) report Bayes factor for the primary outcome, being the ratio of the probability that a given trial result is compatible with a 'null' effect (corresponding to the P-value) divided by the probability that the trial result is compatible with the intervention effect hypothesised in the sample size calculation; (3) adjust the confidence intervals and the statistical significance threshold if the trial is stopped early or if interim analyses have been conducted; (4) adjust the confidence intervals and the P-values for multiplicity due to number of outcome comparisons; and (5) assess clinical significance of the trial results. CONCLUSIONS: If the proposed five-step procedure is followed, this may increase the validity of assessments of intervention effects in randomised clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 3×
“P-values are easily calculated but are often misinterpreted [6,7] and misused [8-10].”
BackgroundCONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Self-citationThe BUGS project: evolution, critique and future directions
Lunn, D., Spiegelhalter, D., Thomas, A., & Best, N. (2009) · Statistics in Medicine · doi:10.1002/sim.3680 · Cited by 1,876
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
Ioannidis, J. P. A. (2005) · JAMA · doi:10.1001/jama.294.2.218 · Cited by 1,465
Research works printed but not linked: 68
- Jakobsen JC, Gluud C: The necessity of randomized clinical trials. Br J Med Res. 2013, 3 (4): 1453-1468. · DOI
- Fisher R: Statistical methods and scientific induction. J R Stat Soc Ser B. 1955, 17 (1): 69-78. · DOI · Paper page
- Hald A: A history of mathematical statistics from 1750 to 1930. 1998, New York: John Wiley & Sons
- Goodman S: A dirty dozen: twelve p-value misconceptions. Semin Hematol. 2008, 45: 135-140. 10.1053/j.seminhematol.2008.04.003. · DOI · Paper page
- Oliveri RS, Gluud C, Wille-Jørgensen PA: Hospital doctors' self-rated skills in and use of evidence-based medicine - a questionnaire survey. J Eval Clin Pract. 2004, 10 (2): 219-226. 10.1111/j.1365-2753.2003.00477.x. · DOI
- Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schunemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, et al: Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010, 303: 1180-1187. 10.1001/jama.2010.310. · DOI · Paper page
- Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, Gluud LL, Als-Nielsen B, Gluud C: Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?. Int J Epidemiol. 2009, 38 (1): 276-286. 10.1093/ije/dyn179. · DOI · Paper page
- Garattini S, Bertele V: Non-inferiority trials are unethical because they disregard patients' interests. Lancet. 2007, 370 (9602): 1875-1877. 10.1016/S0140-6736(07)61604-3. · DOI · Paper page
- Sterne JA: Teaching hypothesis tests–time for significant change?. Stat Med. 2002, 21: 985-999. 10.1002/sim.1129. · DOI
- Ranstam J: Why the P-value culture is bad and confidence intervals a better alternative. Osteoarthritis Cartilage. 2012, 20: 805-808. 10.1016/j.joca.2012.04.001. · DOI
- Williamson PR, Altman DG, Blazeby JM, Clarke M, Gargon E: The COMET (Core Outcome Measures in Effectiveness Trials) Initiative. Trials. 2011, 12 (Suppl 1): A70-10.1186/1745-6215-12-S1-A70. · DOI · Paper page
- Altman DG, Bland JM: How to obtain the confidence interval from a P value. BMJ. 2011, 343: d2090-10.1136/bmj.d2090. · DOI · Paper page
- Chow S-C, Shao J, Wang H: Sample Size Calculations in Clinical Research, Second Edition. 2008, Boca Raton, Florida: Chapman and Hall/CRC
- Scales DC, Rubenfeld GD: Estimating sample size in critical care clinical trials. J Crit Care. 2005, 20 (1): 6-11. 10.1016/j.jcrc.2005.02.002. · DOI
- Myles DJS, Keith RA, Jonathan P: Bayesian approaches to clinical trials and health-care evaluation (Statistics in Practice). 2004, West Sussex, England: John Wiley & Sons
- Roloff V, Higgins JP, Sutton AJ: Planning future studies based on the conditional power of a meta-analysis. Stat Med. 2013, 32 (1): 11-24. 10.1002/sim.5524. · DOI
- Goodman SN: Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials. 2005, 2: 282-378. 10.1191/1740774505cn098oa. · DOI
- Goodman SN: Toward evidence-based medical statistics. 2: The Bayes factor. Ann Int Med. 1999, 130 (12): 1005-1013. 10.7326/0003-4819-130-12-199906150-00019. · DOI · Paper page
- Higgins JP, Whitehead A: Borrowing strength from external trials in a meta-analysis. Stat Med. 1996, 15 (24): 2733-2749. 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0. · DOI · Paper page
- Fayers PM, Cuschieri A, Fielding J, Craven J, Uscinska B, Freedman LS: Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer. 2000, 82 (1): 213-219. 10.1054/bjoc.1999.0902. · DOI
- Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, Guyatt G, Devereaux PJ, Thabane L: The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis-a simulation study. PLoS One. 2011, 6: e25491-10.1371/journal.pone.0025491. · DOI · Paper page
- Pereira TV, Horwitz RI, Ioannidis JP: Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012, 308: 1676-1684. 10.1001/jama.2012.13444. · DOI · Paper page
- Mehta CR, Pocock SJ: Adaptive increase in sample size when interim results are promising: a practical guide with examples. Stat Med. 2011, 30 (28): 3267-3284. 10.1002/sim.4102. · DOI · Paper page
- Jennison C, Turnbull BW: Efficient group sequential designs when there are several effect sizes under consideration. Stat Med. 2005, 25: 917-932. · DOI
- O'Hagan A, Stevens JW, Campbell MJ: Assurance in clinical trial design. Pharm Stat. 2005, 4 (3): 187-201. 10.1002/pst.175. · DOI · Paper page
- Levin GP, Emerson SC, Emerson SS: Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation. Stat Med. 2012, 32 (8): 1259-1275. · DOI
- DeMets DL, Lan KK: Interim analysis: the alpha spending function approach. Stat Med. 1994, 13 (13–14): 1341-1356. · DOI · Paper page
- Bassler D, Montori VM, Briel M, Glasziou P, Walter SD, Ramsay T, Guyatt G: Reflections on meta-analyses involving trials stopped early for benefit: is there a problem and if so, what is it?. Stat Methods Med Res. 2013, 22 (2): 159-168. 10.1177/0962280211432211. · DOI
- Lindley DV: A statistical paradox. Biometrika. 1957, 44 (1/2): 187-192. 10.2307/2333251. · doi:10.2307/2333251
- Wald A: Sequential tests of statistical hypotheses. Ann Math Stat. 1945, 16: 117-186. 10.1214/aoms/1177731118. · DOI · Paper page
- Zhang J, Quan H, Ng J, Stepanavage ME: Some statistical methods for multiple endpoints in clinical trials. Control Clin Trials. 1997, 18: 204-221. 10.1016/S0197-2456(96)00129-8. · DOI · Paper page
- Imberger G, Vejlby AD, Hansen SB, Møller AM, Wetterslev J: Statistical multiplicity in systematic reviews of anaesthesia interventions: a quantification and comparison between Cochrane and non-Cochrane reviews. PLoS One. 2011, 6: e28422-10.1371/journal.pone.0028422. · DOI
- Jennison C, Turnbull BW: Repeated confidence intervals for group sequential clinical trials. Control Clin Trials. 1984, 5 (1): 33-45. 10.1016/0197-2456(84)90148-X. · DOI
- Todd S, Whitehead J, Facey KM: Point and interval estimation following a sequential clinical trial. Biometrika. 1996, 83 (2): 453-461. 10.1093/biomet/83.2.453. · DOI
- Jennison C, Turnbull BW: Group Sequential Methods with Applications to Clinical Trials (Chapman & Hall/CRC Interdisciplinary Statistics). 1999, : Chapman and Hall/CRC · DOI · Paper page
- Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C: User manual for trial sequential analysis (TSA). 2011, Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research, 1-115. Available from http://www.ctu.dk/tsa
- Yang Q, Cui J, Chazaro I, Cupples LA, Demissie S: Power and type I error rate of false discovery rate approaches in genome-wide association studies. BMC Genet. 2005, 6 (Suppl 1): S134-10.1186/1471-2156-6-S1-S134. · DOI
- Altman DG, Bland JM: How to obtain the P value from a confidence interval. BMJ. 2011, 343: d2304-10.1136/bmj.d2304. · DOI · Paper page
- Abdi H: Encyclopedia of Measurement and Statistics. The Bonferonni and Šidák corrections for multiple comparisons. In N.J. Salkind (Ed.) page 103–107. 2007, Thousand Oaks (CA): Sage
- Holm S: A simple sequentially rejective multipletestprocedure. Scand J Statist. 1979, 6: 65-70.
- Dmitrienko A, Ajit C, Tamhane AC, Bretz F: Multiple testing problems in pharmaceutical statistics (Chapman & Hall/CRC Biostatistics Series). 2009, Boca Raton, Florida: Chapman and Hall/CRC · DOI · Paper page
- Tu YH, Cheng B, Cheung YK: A note on confidence bounds after fixed-sequence multiple tests. J Stat Plan Inference. 2012, 142 (11): 2993-2998. 10.1016/j.jspi.2012.05.002. · doi:10.1016/j.jspi.2012.05.002
- Wiens BL, Dmitrienko A: The fallback procedure for evaluating a single family of hypotheses. J Biopharm Stat. 2005, 15 (6): 929-942. 10.1080/10543400500265660. · DOI
- Korn EL, Li MC, McShane LM, Simon R: An investigation of two multivariate permutation methods for controlling the false discovery proportion. Stat Med. 2007, 26 (24): 4428-4440. 10.1002/sim.2865. · DOI
- Westfall PH, Young S: Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment (Wiley Series in Probability and Statistics). 1993, New York: Wiley-Interscience
- Yu J, Hutson AD, Siddiqui AH, Kedron MA: Group sequential control of overall toxicity incidents in clinical trials - non-Bayesian and Bayesian approaches. Stat Methods Med Res. 2012, Epub ahead of print
- Thall PF, Simon RM, Shen Y: Approximate Bayesian evaluation of multiple treatment effects. Biometrics. 2000, 56: 213-219. 10.1111/j.0006-341X.2000.00213.x. · DOI
- Zhang X, Cutter G: Bayesian interim analysis in clinical trials. Contemp Clin Trials. 2008, 29: 751-755. 10.1016/j.cct.2008.05.007. · DOI
- Jakobsen JC, Lindschou Hansen J, Storebø OJ, Simonsen E, Gluud C: The effects of cognitive therapy versus 'treatment as usual' in patients with major depressive disorder. PLoS One. 2011, 6 (8): e22890-10.1371/journal.pone.0022890. · DOI
- Stovring H, Harmsen CG, Wisloff T, Jarbol DE, Nexoe J, Nielsen JB, Kristiansen IS: A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality. Eur J Prev Cardiol. 2012, 20 (5): 827-836. · doi:10.1177/2047487312445425
- Prasad V, Vandross A: Cardiovascular primary prevention: how high should we set the bar?. Arch Int Med. 2012, 172: 656-659. 10.1001/archinternmed.2012.812. · DOI
- Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso-Coello P, Atkins D, Kunz R, Montori V, Jaeschke R, Rind D, Dahm P, Akl EA, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Schunemann HJ: GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol. 2013, 66 (2): 151-157. 10.1016/j.jclinepi.2012.01.006. · DOI · Paper page
- Higgins JPT, Green S: The Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. 2011, The Cochrane Collaboration, Available from http://www.cochrane-handbook.org
- Johnston BC, Thorlund K, Schunemann HJ, Xie F, Murad MH, Montori VM, Guyatt GH: Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes. 2010, 8: 116-10.1186/1477-7525-8-116. · DOI · Paper page
- Halvorsen PA, Kristiansen IS: Decisions on drug therapies by numbers needed to treat: a randomized trial. Arch Int Med. 2005, 165: 1140-1146. 10.1001/archinte.165.10.1140. · DOI
- Chalmers I, Milne I, Trohler U, Vandenbroucke J, Morabia A, Tait G, Dukan E: The James Lind Library: explaining and illustrating the evolution of fair tests of medical treatments. J R Coll Physicians Edinb. 2008, 38 (3): 259-264. · DOI
- Garthwaite P, Kadane JB, O'Hagan A: Statistical Methods for Eliciting Probability Distributions. J Am Stat Assoc. 2012, 100 (470): · DOI · Paper page
- Higgins JP, Whitehead A, Simmonds M: Sequential methods for random-effects meta-analysis. Stat Med. 2011, 30 (9): 903-921. 10.1002/sim.4088. · DOI · Paper page
- Keus F, Wetterslev J, Gluud C, van Laarhoven CJ: Evidence at a glance: error matrix approach for overviewing available evidence. BMC Med Res Methodol. 2010, 10: 90-10.1186/1471-2288-10-90. · DOI · Paper page
- Johnson VE: Uniformly most powerful Bayesian tests. Ann Stat. 2013, 41: 1716-1741. 10.1214/13-AOS1123. · DOI
- Higgins JP, Spiegelhalter DJ: Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol. 2002, 31 (1): 96-104. 10.1093/ije/31.1.96. · DOI
- Korn EL, Freidlin B: The likelihood as statistical evidence in multiple comparisons in clinical trials: no free lunch. Biom J. 2006, 48 (3): 346-355. 10.1002/bimj.200510216. · DOI
- Gaziano JM, Sesso HD, Christen WG, Bubes V, Smith JP, MacFadyen J, Schvartz M, Manson JE, Glynn RJ, Buring JE: Multivitamins in the prevention of cancer in men: the Physicians' Health Study II. JAMA. 2012, 308 (18): 1871-1880. 10.1001/jama.2012.14641. · DOI · Paper page
- Christen WG, Gaziano JM, Hennekens CH: Design of Physicians' Health Study II–a randomized trial of beta-carotene. Ann Epidemiol. 2000, 10 (2): 125-134. 10.1016/S1047-2797(99)00042-3. · DOI · Paper page
- Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C: Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012, 3: CD007176
- Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejia-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S: Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010, 376 (9734): 23-32. · DOI · Paper page
- Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller T, et al: Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Eng J Med. 2012, 367 (2): 124-134. 10.1056/NEJMoa1204242. · DOI · Paper page
- Perner A, Haase N, Wetterslev J, Aneman A, Tenhunen J, Guttormsen AB, Klemenzson G, Pott F, Bodker KD, Badstolokken PM, Bendtsen A, Soe-Jensen P, Tousi H, Bestle M, Pawlowicz M, Winding R, Bulow HH, Kancir C, Steensen M, Nielsen J, Fogh B, Madsen KR, Larsen NH, Carlsson M, Wiis J, Petersen JA, Iversen S, Schoidt O, Leivdal S, Berezowicz P, et al: Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trial. Trials. 2011, 12 (1): 24-10.1186/1745-6215-12-24. · DOI
Cited by
Jakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0442-1 · Cited by 2,747
Self-citationTrial Sequential Analysis in systematic reviews with meta-analysis
Wetterslev, J., Jakobsen, J. C., & Gluud, C. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0315-7 · Cited by 1,189
Self-citationJakobsen, J. C., Wetterslev, J., Winkel, P., Lange, T., & Gluud, C. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-120 · Cited by 704
“following, we have chosen to define the alternative hypothesis (HA) as the anticipated intervention effect used in the calculation of the required information size in the trial sequential analysis (see step 4) [12], but Bayes factor can be defined differently [12].”
BackgroundMethodInfluentialSelf-citationRestriction of Intravenous Fluid in ICU Patients with Septic Shock
Meyhoff, T. S., Hjortrup, P. B., Wetterslev, J., Sivapalan, P., Laake, J. H., Cronhjort, M., Jakob, S. M., Cecconi, M., Nalos, M., Ostermann, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2202707 · Cited by 427
Self-citationJakobsen, J. C., Katakam, K. K., Schou, A., Hellmuth, S. G., Stallknecht, S. E., Leth-Møller, K., Iversen, M., Banke, M. B., Petersen, I. J., Klingenberg, S. L., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1173-2 · Cited by 366
Self-citation
Metadata
- Authors
- Jakobsen, J. C., Gluud, C., Winkel, P., Lange, T., & Wetterslev, J.
- Venue
- BMC Medical Research Methodology
- Published
- 2014-03-04
- Volume
- 14
- Issue
- 1
- Pages
- 34-34
- ISSN
- 1471-2288 (ISSN-L)
- OpenAlex
- W2097687553
- Cited by
- 203
- References
- 21
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The thresholds for statistical and clinical significance – a five-step procedure for evaluation of intervention effects in randomised clinical trials. https://app.cochat.ai/papers/10.1186/1471-2288-14-34
- The paper
- Jakobsen, J. C., Gluud, C., Winkel, P., Lange, T., & Wetterslev, J. (2014). The thresholds for statistical and clinical significance – a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Medical Research Methodology. https://doi.org/10.1186/1471-2288-14-34
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.